content

Mobidiag Ltd Receives Second Tranche of €25M Financing from European Investment Bank

Mobidiag Ltd. announces that it has received the second tranche of €10M from the €25M growth capital loan signed with the European Investment Bank...

TrialSpark announces launch of Project Covalence, a clinical trial platform to rapidly test drugs and diagnostics for COVID-19

TrialSpark, a tech-enabled drug development company committed to improving the speed, quality, and innovation of clinical trials, announced the launch of Project Covalence, a...

Agena Bioscience Announces EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel

Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, announced the launch of the iPLEX® Pro SARS-CoV-2 Panel for qualitative...

Sanofi invests in vaccine research and production

Sanofi detailed plans on how the Company will make significant investments in France to increase its vaccines research and production capacities, and contribute in...

IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology

IDEAYA Biosciences, Inc. and GlaxoSmithKline plc announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology. The strategic partnership includes IDEAYA’s Synthetic Lethality...

Pfizer Announced FDA Approval of Oncology Supportive Care Biosimilar, NYVEPRIA

Pfizer Inc. announced the US FDA has approved NYVEPRIA, a biosimilar to Neulasta NYVEPRIA is indicated to decrease the incidence of infection, as manifested...

Sunovion Announces Health Canada Approval of KYNMOBI Soluble Film for the Treatment of Parkinson’s Disease OFF Episodes

Sunovion Pharmaceuticals Inc. announced that Health Canada has approved KYNMOBI soluble film for the acute, intermittent treatment of OFF episodes in patients with Parkinson’s...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read